Literature DB >> 16461432

Hypoxia upregulates lung microvascular neurokinin-1 receptor expression.

Eric D Zee1, Stacey Schomberg, Todd C Carpenter.   

Abstract

Subacute exposure to moderate hypoxia can promote pulmonary edema formation. The tachykinins, a family of proinflammatory neuropeptides, have been implicated in the pathogenesis of pulmonary edema in some settings, including the pulmonary vascular leak associated with exposure to hypoxia. The effects of hypoxia on tachykinin receptor and peptide expression in the lung, however, remain poorly understood. We hypothesized that subacute exposure to moderate hypoxia increases lung neurokinin-1 (NK-1) receptor expression as well as lung substance P levels. We tested this hypothesis by exposing weanling Sprague-Dawley rats to hypobaric hypoxia (barometric pressure 0.5 atm) for 0, 24, 48, or 72 h. Hypoxia led to time-dependent increases in lung NK-1 receptor mRNA expression and lung NK-1 receptor protein levels at 48 and 72 h of exposure (P < 0.05). Immunohistochemistry and in situ NK-1 receptor labeling with substance P-conjugated fluorescent nanocrystals demonstrated that hypoxia increased NK-1 expression primarily in the pulmonary microvasculature and in alveolar macrophages. Hypoxia also led to increases in lung substance P levels by 48 and 72 h (P < 0.05) but led to a decrease in preprotachykinin mRNA levels (P < 0.05). We conclude that subacute exposure to moderate hypoxia upregulates lung NK-1 receptor expression and lung substance P peptide levels primarily in the lung microvasculature. We speculate that this effect may contribute to the formation of pulmonary edema in the setting of regional or environmental hypoxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461432     DOI: 10.1152/ajplung.00286.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

Review 1.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

2.  Monocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia.

Authors:  Jie Chao; Paula Donham; Nico van Rooijen; John G Wood; Norberto C Gonzalez
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-02       Impact factor: 6.914

Review 3.  Alveolar macrophages initiate the systemic microvascular inflammatory response to alveolar hypoxia.

Authors:  Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  Respir Physiol Neurobiol       Date:  2011-03-21       Impact factor: 1.931

4.  Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors:  Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

5.  Association of Age with the Expression of Hypoxia-Inducible Factors HIF-1α, HIF-2α, HIF-3α and VEGF in Lung and Heart of Tibetan Sheep.

Authors:  Yanyu He; John S Munday; Matthew Perrott; Guan Wang; Xiu Liu
Journal:  Animals (Basel)       Date:  2019-09-11       Impact factor: 2.752

Review 6.  Alveolar hypoxia, alveolar macrophages, and systemic inflammation.

Authors:  Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  Respir Res       Date:  2009-06-22

7.  Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways.

Authors:  Jitesh D Kawedia; Fan Yang; Maureen A Sartor; David Gozal; Maria Czyzyk-Krzeska; Anil G Menon
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.